Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Photodiagnosis and Photodynamic Therapy|May 12, 2015
Photodynamic therapy (PDT) for malignant brain tumors--where do we stand?Brendan J Quirk, Garth Brandal, Steven Donlon, et al.
Oncotarget|January 20, 2018
Acid ceramidase and its inhibitors: a de novo drug target and a new class of drugs for killing glioblastoma cancer stem cells with high efficiencyNinh B Doan, Hisham Alhajala, Mona M Al-Gizawiy, et al.
Physiological Genomics|May 8, 2014
Comprehensive characterization of glioblastoma tumor tissues for biomarker identification using mass spectrometry-based label-free quantitative proteomicsMaxime S Heroux, Marla A Chesnik, Brian D Halligan, et al.
Frontiers in Oncology|December 23, 2022
Case report: Fractional brain tumor burden magnetic resonance mapping to assess response to pulsed low-dose-rate radiotherapy in newly-diagnosed glioblastomaRyan F Amidon, Fernando Santos-Pinheiro, Michael Straza, et al.
Neurosurgery|March 19, 2024
Noninvasive Autopsy-Validated Tumor Probability Maps Identify Glioma Invasion Beyond Contrast EnhancementSamuel A Bobholz, Allison K Lowman, Jennifer M Connelly, et al.
CNS Oncology|November 13, 2024
Radio-pathomic estimates of cellular growth kinetics predict survival in recurrent glioblastomaSonoko Oshima, Jingwen Yao, Samuel Bobholz, et al.
Cancer|March 11, 2020
NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcomaEudocia Q Lee, Peixin Zhang, Patrick Y Wen, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
Tumor-initiating genetics and therapy drive divergent molecular evolution in IDH-mutant gliomasTamrin Chowdhury, C Mircea S Tesileanu, Emre Kocakavuk, et al.
Pageof 3